nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—schizophrenia	0.725	1	CbGaD
Orlistat—PLA2G7—blood plasma—schizophrenia	0.00863	0.0806	CbGeAlD
Orlistat—PNLIP—blood plasma—schizophrenia	0.00758	0.0709	CbGeAlD
Orlistat—DAGLA—forebrain—schizophrenia	0.00755	0.0705	CbGeAlD
Orlistat—DAGLA—blood—schizophrenia	0.00505	0.0472	CbGeAlD
Orlistat—DAGLA—nervous system—schizophrenia	0.0041	0.0383	CbGeAlD
Orlistat—DAGLA—central nervous system—schizophrenia	0.00394	0.0369	CbGeAlD
Orlistat—DAGLA—cerebellum—schizophrenia	0.00385	0.036	CbGeAlD
Orlistat—FASN—telencephalon—schizophrenia	0.00321	0.03	CbGeAlD
Orlistat—PLA2G7—blood—schizophrenia	0.00316	0.0295	CbGeAlD
Orlistat—DAGLA—brain—schizophrenia	0.00313	0.0293	CbGeAlD
Orlistat—PLA2G7—midbrain—schizophrenia	0.00312	0.0292	CbGeAlD
Orlistat—PLA2G4A—blood plasma—schizophrenia	0.00306	0.0286	CbGeAlD
Orlistat—DAGLB—cerebellum—schizophrenia	0.00299	0.0279	CbGeAlD
Orlistat—ABHD16A—blood—schizophrenia	0.00297	0.0277	CbGeAlD
Orlistat—ABHD16A—midbrain—schizophrenia	0.00293	0.0274	CbGeAlD
Orlistat—ABHD12—blood—schizophrenia	0.00278	0.026	CbGeAlD
Orlistat—PNLIP—blood—schizophrenia	0.00278	0.026	CbGeAlD
Orlistat—ABHD12—midbrain—schizophrenia	0.00274	0.0257	CbGeAlD
Orlistat—PLA2G7—endocrine gland—schizophrenia	0.00274	0.0256	CbGeAlD
Orlistat—DAGLB—brain—schizophrenia	0.00243	0.0227	CbGeAlD
Orlistat—PNLIP—endocrine gland—schizophrenia	0.00241	0.0225	CbGeAlD
Orlistat—FASN—blood—schizophrenia	0.00233	0.0218	CbGeAlD
Orlistat—FASN—midbrain—schizophrenia	0.0023	0.0215	CbGeAlD
Orlistat—ABHD16A—cerebellum—schizophrenia	0.00227	0.0212	CbGeAlD
Orlistat—ABHD12—cerebellum—schizophrenia	0.00212	0.0198	CbGeAlD
Orlistat—PLA2G7—brain—schizophrenia	0.00196	0.0183	CbGeAlD
Orlistat—CYP3A4—urine—schizophrenia	0.00193	0.0181	CbGeAlD
Orlistat—FASN—cerebellum—schizophrenia	0.00178	0.0167	CbGeAlD
Orlistat—ABHD12—brain—schizophrenia	0.00172	0.0161	CbGeAlD
Orlistat—FASN—brain—schizophrenia	0.00145	0.0135	CbGeAlD
Orlistat—PLA2G4A—blood—schizophrenia	0.00112	0.0105	CbGeAlD
Orlistat—PLA2G4A—midbrain—schizophrenia	0.00111	0.0103	CbGeAlD
Orlistat—CYP3A4—blood plasma—schizophrenia	0.00101	0.00944	CbGeAlD
Orlistat—PLA2G4A—endocrine gland—schizophrenia	0.000972	0.00909	CbGeAlD
Orlistat—PLA2G4A—nervous system—schizophrenia	0.00091	0.00851	CbGeAlD
Orlistat—PLA2G4A—central nervous system—schizophrenia	0.000876	0.00819	CbGeAlD
Orlistat—PLA2G4A—brain—schizophrenia	0.000696	0.0065	CbGeAlD
Orlistat—CYP3A4—blood—schizophrenia	0.00037	0.00346	CbGeAlD
Orlistat—CYP3A4—endocrine gland—schizophrenia	0.000321	0.003	CbGeAlD
Orlistat—CYP3A4—nervous system—schizophrenia	0.0003	0.00281	CbGeAlD
Orlistat—CYP3A4—central nervous system—schizophrenia	0.000289	0.0027	CbGeAlD
Orlistat—DAGLB—Hemostasis—TP53—schizophrenia	5.18e-05	0.000307	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—schizophrenia	5.18e-05	0.000307	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PRL—schizophrenia	5.17e-05	0.000307	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NRG1—schizophrenia	5.13e-05	0.000305	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NRG1—schizophrenia	5.13e-05	0.000305	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GCLM—schizophrenia	5.13e-05	0.000305	CbGpPWpGaD
Orlistat—PNLIP—Disease—APOE—schizophrenia	5.09e-05	0.000302	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MEF2C—schizophrenia	5.09e-05	0.000302	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MEF2C—schizophrenia	5.09e-05	0.000302	CbGpPWpGaD
Orlistat—PNLIP—Disease—APOA1—schizophrenia	5.03e-05	0.000299	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS1—schizophrenia	4.99e-05	0.000296	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NDUFV2—schizophrenia	4.94e-05	0.000294	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—YWHAZ—schizophrenia	4.92e-05	0.000292	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—YWHAZ—schizophrenia	4.92e-05	0.000292	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DGKI—schizophrenia	4.86e-05	0.000289	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CHRM1—schizophrenia	4.85e-05	0.000288	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—S100B—schizophrenia	4.82e-05	0.000286	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ERBB3—schizophrenia	4.81e-05	0.000285	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ERBB3—schizophrenia	4.81e-05	0.000285	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP1A2—schizophrenia	4.78e-05	0.000284	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL3RA—schizophrenia	4.73e-05	0.000281	CbGpPWpGaD
Orlistat—FASN—Metabolism—TH—schizophrenia	4.71e-05	0.00028	CbGpPWpGaD
Orlistat—FASN—Disease—ERBB4—schizophrenia	4.66e-05	0.000276	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIP4K2A—schizophrenia	4.65e-05	0.000276	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2A—schizophrenia	4.63e-05	0.000275	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2A—schizophrenia	4.63e-05	0.000275	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	4.61e-05	0.000274	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ERBB4—schizophrenia	4.61e-05	0.000274	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MTHFR—schizophrenia	4.58e-05	0.000272	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GRM5—schizophrenia	4.51e-05	0.000268	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP1R1B—schizophrenia	4.45e-05	0.000264	CbGpPWpGaD
Orlistat—PNLIP—Disease—GSK3B—schizophrenia	4.41e-05	0.000262	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	4.4e-05	0.000261	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—AKT1—schizophrenia	4.37e-05	0.000259	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—AKT1—schizophrenia	4.37e-05	0.000259	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PLA2G4A—schizophrenia	4.33e-05	0.000257	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOE—schizophrenia	4.3e-05	0.000255	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOE—schizophrenia	4.3e-05	0.000255	CbGpPWpGaD
Orlistat—FASN—Disease—NRG1—schizophrenia	4.3e-05	0.000255	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOE—schizophrenia	4.26e-05	0.000253	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NRG1—schizophrenia	4.25e-05	0.000253	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOA1—schizophrenia	4.25e-05	0.000253	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOA1—schizophrenia	4.25e-05	0.000253	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MEF2C—schizophrenia	4.22e-05	0.00025	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOA1—schizophrenia	4.22e-05	0.00025	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP26B1—schizophrenia	4.2e-05	0.00025	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FZD3—schizophrenia	4.13e-05	0.000245	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCK—schizophrenia	4.12e-05	0.000245	CbGpPWpGaD
Orlistat—FASN—Disease—YWHAZ—schizophrenia	4.12e-05	0.000244	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ESR1—schizophrenia	4.11e-05	0.000244	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ESR1—schizophrenia	4.11e-05	0.000244	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—YWHAZ—schizophrenia	4.07e-05	0.000242	CbGpPWpGaD
Orlistat—FASN—Disease—ERBB3—schizophrenia	4.03e-05	0.000239	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PDE4B—schizophrenia	4.02e-05	0.000239	CbGpPWpGaD
Orlistat—FASN—Metabolism—COMT—schizophrenia	4.01e-05	0.000238	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTP1—schizophrenia	3.99e-05	0.000237	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ERBB3—schizophrenia	3.98e-05	0.000237	CbGpPWpGaD
Orlistat—FASN—Metabolism—MAOA—schizophrenia	3.98e-05	0.000236	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.97e-05	0.000236	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCKAR—schizophrenia	3.95e-05	0.000235	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GRM2—schizophrenia	3.89e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FES—schizophrenia	3.89e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP3CC—schizophrenia	3.89e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TAAR6—schizophrenia	3.89e-05	0.000231	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—schizophrenia	3.87e-05	0.00023	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.86e-05	0.000229	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—schizophrenia	3.84e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADORA2A—schizophrenia	3.83e-05	0.000228	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCB1—schizophrenia	3.78e-05	0.000224	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GCLM—schizophrenia	3.75e-05	0.000222	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TPH1—schizophrenia	3.75e-05	0.000222	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GSK3B—schizophrenia	3.73e-05	0.000221	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GSK3B—schizophrenia	3.73e-05	0.000221	CbGpPWpGaD
Orlistat—FASN—Metabolism—PLA2G4A—schizophrenia	3.67e-05	0.000218	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTM1—schizophrenia	3.67e-05	0.000218	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—YWHAZ—schizophrenia	3.65e-05	0.000217	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—schizophrenia	3.6e-05	0.000214	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NGEF—schizophrenia	3.6e-05	0.000214	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPY—schizophrenia	3.58e-05	0.000213	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—schizophrenia	3.57e-05	0.000212	CbGpPWpGaD
Orlistat—FASN—Disease—APOA1—schizophrenia	3.56e-05	0.000211	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOA1—schizophrenia	3.52e-05	0.000209	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PRKD1—schizophrenia	3.52e-05	0.000209	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTS—schizophrenia	3.52e-05	0.000209	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1B—schizophrenia	3.46e-05	0.000205	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OXT—schizophrenia	3.46e-05	0.000205	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ESR1—schizophrenia	3.4e-05	0.000202	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1A—schizophrenia	3.33e-05	0.000198	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RTN4—schizophrenia	3.3e-05	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RGS4—schizophrenia	3.3e-05	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GRM3—schizophrenia	3.3e-05	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPS—schizophrenia	3.28e-05	0.000195	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR6—schizophrenia	3.24e-05	0.000193	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—schizophrenia	3.24e-05	0.000192	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	3.22e-05	0.000191	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2C—schizophrenia	3.21e-05	0.000191	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD1—schizophrenia	3.21e-05	0.000191	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—APOA1—schizophrenia	3.16e-05	0.000187	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAG—schizophrenia	3.13e-05	0.000186	CbGpPWpGaD
Orlistat—FASN—Disease—GSK3B—schizophrenia	3.12e-05	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD3—schizophrenia	3.11e-05	0.000185	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	3.11e-05	0.000185	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GSK3B—schizophrenia	3.09e-05	0.000183	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	3.07e-05	0.000182	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD4—schizophrenia	3.02e-05	0.000179	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—schizophrenia	3.02e-05	0.000179	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOA1—schizophrenia	2.98e-05	0.000177	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GAPDH—schizophrenia	2.94e-05	0.000175	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CLOCK—schizophrenia	2.91e-05	0.000173	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.91e-05	0.000173	CbGpPWpGaD
Orlistat—PNLIP—Disease—EP300—schizophrenia	2.9e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CNR1—schizophrenia	2.88e-05	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.87e-05	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CHRM1—schizophrenia	2.87e-05	0.00017	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TPH2—schizophrenia	2.84e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNB2—schizophrenia	2.84e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.84e-05	0.000169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR7—schizophrenia	2.81e-05	0.000167	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD2—schizophrenia	2.81e-05	0.000167	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	2.81e-05	0.000167	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DPYD—schizophrenia	2.79e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL3RA—schizophrenia	2.79e-05	0.000166	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	2.77e-05	0.000165	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AKT1—schizophrenia	2.76e-05	0.000164	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AKT1—schizophrenia	2.76e-05	0.000164	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NRG3—schizophrenia	2.73e-05	0.000162	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TLE1—schizophrenia	2.73e-05	0.000162	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GFAP—schizophrenia	2.69e-05	0.00016	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GRM5—schizophrenia	2.66e-05	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNA1C—schizophrenia	2.6e-05	0.000154	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TLE3—schizophrenia	2.58e-05	0.000153	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3C2A—schizophrenia	2.53e-05	0.00015	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AKT1—schizophrenia	2.51e-05	0.000149	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AKT1—schizophrenia	2.51e-05	0.000149	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EP300—schizophrenia	2.45e-05	0.000146	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EP300—schizophrenia	2.45e-05	0.000146	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCK—schizophrenia	2.44e-05	0.000145	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EP300—schizophrenia	2.43e-05	0.000144	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.4e-05	0.000142	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDE4B—schizophrenia	2.37e-05	0.000141	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—COMT—schizophrenia	2.36e-05	0.00014	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTP1—schizophrenia	2.34e-05	0.000139	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—MAOA—schizophrenia	2.34e-05	0.000139	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCKAR—schizophrenia	2.34e-05	0.000139	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	2.32e-05	0.000138	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	2.31e-05	0.000137	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP2D6—schizophrenia	2.27e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SNAP25—schizophrenia	2.27e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADORA2A—schizophrenia	2.27e-05	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGA—schizophrenia	2.17e-05	0.000129	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTM1—schizophrenia	2.15e-05	0.000128	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—schizophrenia	2.13e-05	0.000127	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	2.13e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPY—schizophrenia	2.12e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ATP2A2—schizophrenia	2.12e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH4—schizophrenia	2.12e-05	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP1A2—schizophrenia	2.05e-05	0.000122	CbGpPWpGaD
Orlistat—FASN—Disease—EP300—schizophrenia	2.05e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1B—schizophrenia	2.04e-05	0.000121	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OXT—schizophrenia	2.04e-05	0.000121	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EP300—schizophrenia	2.03e-05	0.000121	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TH—schizophrenia	2.02e-05	0.00012	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PRODH—schizophrenia	2.02e-05	0.00012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—schizophrenia	1.97e-05	0.000117	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1A—schizophrenia	1.97e-05	0.000117	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPS—schizophrenia	1.94e-05	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2C—schizophrenia	1.9e-05	0.000113	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD1—schizophrenia	1.9e-05	0.000113	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK2—schizophrenia	1.85e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD3—schizophrenia	1.84e-05	0.000109	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EP300—schizophrenia	1.82e-05	0.000108	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD4—schizophrenia	1.78e-05	0.000106	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—schizophrenia	1.75e-05	0.000104	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—schizophrenia	1.75e-05	0.000104	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—schizophrenia	1.75e-05	0.000104	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—COMT—schizophrenia	1.72e-05	0.000102	CbGpPWpGaD
Orlistat—FASN—Metabolism—EP300—schizophrenia	1.72e-05	0.000102	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTP1—schizophrenia	1.71e-05	0.000102	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOA—schizophrenia	1.71e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CNR1—schizophrenia	1.7e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD2—schizophrenia	1.66e-05	9.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR7—schizophrenia	1.66e-05	9.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.66e-05	9.83e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MPC2—schizophrenia	1.64e-05	9.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCB1—schizophrenia	1.62e-05	9.62e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—schizophrenia	1.57e-05	9.34e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRL—schizophrenia	1.57e-05	9.32e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCH2—schizophrenia	1.53e-05	9.07e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—schizophrenia	1.48e-05	8.8e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—schizophrenia	1.48e-05	8.8e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—schizophrenia	1.47e-05	8.72e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—S100B—schizophrenia	1.46e-05	8.69e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—schizophrenia	1.45e-05	8.63e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDST3—schizophrenia	1.44e-05	8.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB4—schizophrenia	1.4e-05	8.31e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—schizophrenia	1.39e-05	8.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ACSL6—schizophrenia	1.36e-05	8.08e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC27A5—schizophrenia	1.36e-05	8.08e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—schizophrenia	1.3e-05	7.73e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DAO—schizophrenia	1.3e-05	7.71e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—schizophrenia	1.29e-05	7.69e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NRG1—schizophrenia	1.29e-05	7.67e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MEF2C—schizophrenia	1.28e-05	7.6e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOA1—schizophrenia	1.28e-05	7.6e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PNP—schizophrenia	1.25e-05	7.39e-05	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—schizophrenia	1.24e-05	7.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—YWHAZ—schizophrenia	1.24e-05	7.34e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—schizophrenia	1.23e-05	7.29e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB3—schizophrenia	1.21e-05	7.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—schizophrenia	1.16e-05	6.91e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.16e-05	6.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—schizophrenia	1.1e-05	6.53e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.09e-05	6.46e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—schizophrenia	1.08e-05	6.43e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOA1—schizophrenia	1.07e-05	6.35e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—schizophrenia	1.04e-05	6.17e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ESR1—schizophrenia	1.03e-05	6.14e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP26B1—schizophrenia	9.85e-06	5.84e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3B—schizophrenia	9.37e-06	5.57e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TPH1—schizophrenia	8.77e-06	5.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCLM—schizophrenia	8.77e-06	5.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PRKD1—schizophrenia	8.25e-06	4.9e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EP300—schizophrenia	7.38e-06	4.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GAPDH—schizophrenia	6.89e-06	4.09e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CLOCK—schizophrenia	6.82e-06	4.05e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TPH2—schizophrenia	6.65e-06	3.95e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNB2—schizophrenia	6.65e-06	3.95e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DPYD—schizophrenia	6.54e-06	3.88e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—schizophrenia	6.31e-06	3.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EP300—schizophrenia	6.17e-06	3.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNA1C—schizophrenia	6.08e-06	3.61e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3C2A—schizophrenia	5.93e-06	3.52e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2D6—schizophrenia	5.32e-06	3.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SNAP25—schizophrenia	5.32e-06	3.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP1A2—schizophrenia	4.81e-06	2.85e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TH—schizophrenia	4.74e-06	2.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—schizophrenia	4.46e-06	2.65e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—schizophrenia	4.41e-06	2.62e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—COMT—schizophrenia	4.03e-06	2.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTP1—schizophrenia	4.01e-06	2.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOA—schizophrenia	4e-06	2.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCB1—schizophrenia	3.8e-06	2.25e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—schizophrenia	3.73e-06	2.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.69e-06	2.19e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—schizophrenia	3.69e-06	2.19e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—schizophrenia	3.26e-06	1.93e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—schizophrenia	3.03e-06	1.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA1—schizophrenia	3e-06	1.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EP300—schizophrenia	1.73e-06	1.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—schizophrenia	1.04e-06	6.2e-06	CbGpPWpGaD
